POSSIBILITIES AND LIMITS OF THERAPY IN A CASE OF HYPOCHONDROPLASIA

• मुख्य लेखकों: Monica Alexoae (लेखक), Aurica Rugina (लेखक), Evelina Moraru (लेखक), Ileana Ioniuc (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Amaltea Medical Publishing House, 2014-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Hypocondroplasia is an autosomal dominant genetic disease caused by mutations in the receptor 3 of the fi broblast growth factor gene. The short stature's negative impact on quality of life can be improved by early diagnosis and prompt recombinant growth hormone therapy. The authors present the...